Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients

Abstract

Patients with rheumatoid arthritis (RA) have an increased incidence of cardiovascular events. Ultrasound examination of the carotid arteries can show the presence of plaques and detect the atherosclerotic subclinical process through the evaluation of intima-media thickness (cIMT) and carotid segmental distensibility (cCD). The aim of the present study was to identify which factors could independently influence the evolution of atherosclerosis (plaques, cIMT, and cCD) after 1 year of follow-up in a sample of patients with RA. A total of 137 patients with RA without previous cardiovascular (CV) events were enrolled at baseline, and 105 (M/F: 21/84, age 59.34 ± 11.65 years) were reassessed after one year using ultrasound of carotid arteries to detect atheromatous plaques and to measure cIMT and cCD. After one year, all the indices of subclinical atherosclerosis worsened with respect to baseline (Δ-cIMT = 0.030 ± 0.10 mm, p = 0.005; Δ-cCD = −1.64 ± 4.83, 10–3/KPa, p = 0.005; Δ-plaques = 8.6%, p = 0.035). Traditional CV risk factors (age, mean arterial pressure, and diabetes) and corticosteroid therapy were independently associated with the worsening of subclinical atherosclerosis. Interestingly, when considering RA patients divided according to the degree of disease activity score 28 with C-reactive protein (DAS28 [CRP] ≥2.6), the worsening of subclinical atherosclerosis indices was detectable exclusively in the group of patients with active disease. Our longitudinal study supports the hypothesis of a key role of both traditional CV risk factors and the inflammatory activity of arthritic disease in the progression of subclinical atherosclerosis in RA patients. In addition, corticosteroids might have a deleterious effect.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Meune C, Touzé E, Trinquart L, Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis. 2010;103:253–61.

    PubMed  Article  Google Scholar 

  2. 2.

    Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–67.

    PubMed  Article  Google Scholar 

  3. 3.

    Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987–98. Am J Epidemiol. 2002;155:38–47.

    PubMed  Article  Google Scholar 

  4. 4.

    Wah-Suarez MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, et al. The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients. Clin Rheumatol. 2018;37:2373–80.

    PubMed  Article  Google Scholar 

  5. 5.

    Dalbeni A, Giollo A, Tagetti A, Atanasio S, Orsolini G, Cioffi G, et al. Traditional cardiovascular risk factors or inflammation: which factors accelerate atherosclerosis in arthritis patients? Int J Cardiol. 2017. https://doi.org/10.1016/j.ijcard.2017.01.072.

    PubMed  Article  Google Scholar 

  6. 6.

    Wah-Suarez MI, Galarza-Delgado MA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Abundis-Marquez EE, Davila-Jimene JA, et al. Carotid ultrasound findings in rheumatoid arthritis and control subjects: a case-control study. Int J Rheum Dis. 2018. https://doi.org/10.1111/1756-185X.13377.

    PubMed  Article  Google Scholar 

  7. 7.

    [ESC guidelines 2015. Non-ST-elevation acute coronary syndrome]. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/26545604. Accessed: 28th November 2019.

  8. 8.

    Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC). Eur Heart J. 2016;37:267–315.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929–49.

    PubMed  Article  Google Scholar 

  10. 10.

    Jauch EC, Saver JL, Adams HPJr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.

    PubMed  Article  Google Scholar 

  11. 11.

    Hallert E, Husberg M, Skogh T. 28-Joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project. Rheumatol (Oxf). 2011;50:1259–67.

    Article  Google Scholar 

  12. 12.

    Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Faita F, Gemignani V, Bianchini E, Giannarelli C, Demi M. Real-time measurement system for the evaluation of the intima media thickness with a new edge detector. Conf Proc IEEE Eng Med Biol Soc. 2006;1:715–8.

    Article  Google Scholar 

  14. 14.

    Antignani PL, Benedetti-Valentini F, Aluigi L, Baroncelli TA, Camporese G, Failla G, et al. Diagnosis of vascular diseases. Ultrasound investigations–guidelines. Int Angiol. 2012;31:1–77.

    CAS  PubMed  Google Scholar 

  15. 15.

    Bianchini E, Bruno RM, Corciu AI, Faita F, Gemignani V, Ghiadoni L, et al. Assessment of carotid elasticity during exercise: a reproducibility study. Ultrasound Med Biol. 2012;38:223–30.

    PubMed  Article  Google Scholar 

  16. 16.

    Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004–6–2011). Cerebrovasc Dis. 2012;34:290–6.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol. 2010;30:1014–26.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Van Sijl AM, Van Den Hurk K, Peters MJL, Van Halm VP, Nijpels G, Coen DA, et al. Different type of carotid arterial wall remodeling in rheumatoid arthritis compared with healthy subjects: a case-control study. J Rheumatol. 2012;39:2261–6.

    PubMed  Article  Google Scholar 

  19. 19.

    Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost. 2015;113:916–30.

    PubMed  Article  Google Scholar 

  20. 20.

    Nagata-Sakurai M, Inaba M, Goto H, Kumeda Y, Furumitsu Y, Inui K, et al. Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48:3061–7.

    PubMed  Article  Google Scholar 

  21. 21.

    Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. Effect of anti–tumor necrosis factor α therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 2006;55:150–3.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Burggraaf B, van Breukelen-van der Stoep DB, de Vries MA, Klop B, van Zeben J, van de Geijn JGM, et al. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome. Atherosclerosis. 2018;271:84–91.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Hyun ImC, Kim NR, Wan Kang J, Hun Kim J, Young Kang J, Bum Bae G, et al. Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis. Rheumatology. 2015;54:808–15.

    Article  Google Scholar 

  24. 24.

    Giles JT, Post WS, Blumenthal RS, Polak S, Petri M, Gelber AC, et al. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2011;63:3216–25.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Aviña-Zubieta JA, Abrahamowicz M, De Vera MA, K. Choi H, Sayre E, Mushfiqur Rahman M, et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology. 2013;52:68–75.

    PubMed  Article  Google Scholar 

  26. 26.

    Hernandez-Hernandez V, Ferraz-Amaro I, Diaz-Gonzalez F. Influence of disease activity on the physical activity of rheumatoid arthritis patients. Rheumatology. 2014;53:722–31.

    PubMed  Article  Google Scholar 

  27. 27.

    Metsios G, Stavropoulos-Kalinoglou A, Panoulas VA, Wilson M, Nevill AM, Koutedakis Y, et al. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil. 2009;16:188–94.

    PubMed  Article  Google Scholar 

  28. 28.

    van den Berg MH, de Boer IG, le Cessie S, Breedveld FC, Vliet Vlieland TPM. Are patients with rheumatoid arthritis less physically active than the general population? JCR J Clin Rheumatol. 2007;13:181–6.

    PubMed  Article  Google Scholar 

  29. 29.

    Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming A, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:480–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    del Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol (Hoboken, N. J). 2014;66:264–72.

    Article  Google Scholar 

  31. 31.

    Lindhardsen J, Hilmar Gislason G, Jacobsen S, Ahlehoff O, Schjerning Olsen AM, Rintek Madsen O, et al. Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis. 2014;73:1515–21.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Arida A, Protogerou AD, Konstantonis G, Fragiadaki K, Kitas GD, Sfikakis PP, et al. Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities. Rheumatology. 2017;56:934–9.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Liu H, Cao YH, Sun Di, Jin JL, Zhang HW, Yuan-Lin Guo, et al. High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes. Hypertens Res. 2019;42:1783–93.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Hansson GK. Atherosclerosis—An immune disease. Atherosclerosis. 2009;202:2–10.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DS, Gregson J, Willeit P, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205–13.

    PubMed Central  Article  Google Scholar 

  36. 36.

    England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Reiss AB, Silverman A, Khalfan M, Vernice NA, Kasselman LJ, Carsons SE, et al. Accelerated atherosclerosis in rheumatoid arthritis: mechanisms and treatment. Curr Pharm Des. 2019;25:969–86.

    CAS  Article  Google Scholar 

  38. 38.

    Onal EM, Afsar B, Covic A, Vaziri ND, Kanbay M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertension Res. 2019;42:123–40.

    Article  Google Scholar 

  39. 39.

    Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016. https://doi.org/10.1136/annrheumdis-2016-209775.

    PubMed  Article  Google Scholar 

Download references

Acknowledgements

We thank our colleagues in the Medical Unit of Rheumatology and General Internal Medicine for their assistance and comments that greatly improved the paper.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrea Dalbeni.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

We declare that our study complies with the Declaration of Helsinki, that the locally appointed ethics committee has approved the research protocol.

Informed consent

The informed consent has been obtained from all the recruited subjects.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dalbeni, A., Giollo, A., Bevilacqua, M. et al. Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients. Hypertens Res 43, 922–928 (2020). https://doi.org/10.1038/s41440-020-0441-1

Download citation

Keywords

  • Traditional cardiovascular risk factors
  • Subclinical atherosclerosis
  • Rheumatoid arthritis
  • Residual disease activity

Search